Prostate, Hepatic, and Osseous Lesions on 18F-DCFPyL PET/CT
Clinical Nuclear Medicine Open · 2026-06 · 3 (2)
DOI: 10.1097/nm9.0000000000000067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nuclear Medicine Open, 2026-06. Verfasst von Saurabh Jindal und 5 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Prostate-specific membrane antigen (PSMA) targeting PET imaging has an established role in prostate carcinoma for staging, recurrence evaluation, and selection for PSMA-targeted radiopharmaceutical therapy. We report a case with PSMA avid prostate, hepatic, and osseous lesions in a patient with synchronous malignancies complicating management.
Zitieren
APA
Jindal, S., Manna, S., Kelly, J. E., Li, J., Dehner, L., & Parihar, A. S. (2026). Prostate, Hepatic, and Osseous Lesions on 18F-DCFPyL PET/CT. Clinical Nuclear Medicine Open, 3(2). https://doi.org/10.1097/nm9.0000000000000067
Vancouver
Jindal S, Manna S, Kelly JE, Li J, Dehner L, Parihar AS. Prostate, Hepatic, and Osseous Lesions on 18F-DCFPyL PET/CT. Clinical Nuclear Medicine Open. 2026;3(2). doi:10.1097/nm9.0000000000000067
BibTeX
@article{Jindal2026,
author = {Jindal, Saurabh and Manna, Sayan and Kelly, James E. and Li, Jiannan and Dehner, Louis and Parihar, Ashwin Singh},
title = {Prostate, Hepatic, and Osseous Lesions on 18F-DCFPyL PET/CT},
journal = {Clinical Nuclear Medicine Open},
year = {2026},
volume = {3},
number = {2},
doi = {10.1097/nm9.0000000000000067}
}
EUVIMED